Galectin-3 Marker Expression in Renal Cell Carcinoma and Correlation with patient Clinicopathologic Factors: A cross-sectional study
Background: Renal Cell Carcinoma is one of the most common malignancies worldwide. To date, multiple attempts had been made to accurately diagnose it and predict its behavior. One of the most intriguing biomarkers that have been assessed since 90s, is galectin-3. This study aimed to increase the pri...
Saved in:
Main Authors: | Ghodsieh Kamrani (Author), Reza Havaspour (Author), Mohammad Ranaee (Author), Hamid Shafi (Author), Hoda Shirafkan (Author), Mohammad Ebrahim Sohrabi (Author), Davoud Jahansouz (Author) |
---|---|
Format: | Book |
Published: |
Babol University of Medical Sciences,
2025-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Galectin-3 as an early marker of diastolic dysfunction in children with end-stage renal disease on regular hemodialysis
by: Akram Elsadek, et al.
Published: (2022) -
Galectin-3 as a Marker of Cardiorenal Syndrome in Patients with Chronic Heart Failure
by: V. I. Podzolkov, et al.
Published: (2022) -
Galectin-3: A Novel Marker for the Prediction of Stroke Incidence and Clinical Prognosis
by: Ahmed Sayed, et al.
Published: (2022) -
Bilateral Synchronous Testis Tumors of Different Histology: A Case Report
by: Ghasem Rostami, et al.
Published: (2020) -
Galectins and galectin-mediated autophagy regulation: new insights into targeted cancer therapy
by: Dan Liu, et al.
Published: (2023)